Atara Biotherapeutics (ATRA) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…

Atara Biotherapeutics (ATRA) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: April 20, 2025 (13:23)

Sector: Healthcare

The share price of Atara Biotherapeutics, Inc. (ATRA) now

Latest session on the 17th of April for
Atara Biotherapeutics, Inc. is positive
Trading Volume: 23959
Open: 5.84 /  High: 6.18 /  Low: 5.62
Current value: $6.17
What analysts predict: $14
52-week High/Low: $19 / $5.0
50-Day Moving Average: $6.99 — resistance level today
200-Day Moving Average: $9.07 — resistance level today

Are you interested in Atara Biotherapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Atara Biotherapeutics stock price in 2025, 2026, 2027. How much will one Atara Biotherapeutics share be worth in 2025 - 2027?

When should I take profit in Atara Biotherapeutics stock? When should I record a loss on Atara Biotherapeutics stock? What are analysts' forecasts for Atara Biotherapeutics stock? What is the future of Atara Biotherapeutics stock? We forecast Atara Biotherapeutics stock performance using neural networks based on historical data on Atara Biotherapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Atara Biotherapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Atara Biotherapeutics shares. This happens once a day.


Historical and forecast chart of Atara Biotherapeutics stock

The chart below shows the historical price of Atara Biotherapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Atara Biotherapeutics stock price can be found in the table below.

Long-term forecasts by years.

Atara Biotherapeutic, Inc., a turnkey T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. He is developing tabelecleucel, a T-cell immunotherapy phase III clinical trial for the treatment of rituximab-refractory Epstein-Barr virus (EBV) associated with post-transplant lymphoproliferative disorder, as well as other EBV-related hematological and solid tumors, including carcinoma of the nasopharynx. The company is also developing next-generation CAR T immunotherapy for patients with hematologic malignancies and solid tumors, as well as viral diseases, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 For B-cell lymphomas, and ATA188, which are in phase I clinical trials for the treatment of multiple sclerosis. He also develops ATA2321 for acute myeloid leukemia; ATA230 for cytomegalovirus; ATA368 for HPV; ATA520 for Wilms tumor 1; and ATA621 for BK and JCV. The company has a licensing agreement with the Sloan Kettering Memorial Cancer Center; a license agreement for cooperation in research and development with the Kimr Berghofer Medical Research Institute; and strategic cooperation with the H. Lee Moffitt Cancer Center. Atara Biotherapeutic, Inc. The company was founded in 2012 and is headquartered in South San Francisco, California.

Trending Themes in the Healthcare Sector

Atara Biotherapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 22 6.42 6.27 6.49 3.60
Apr 23 6.40 6.29 6.51 3.45
Apr 24 6.44 6.30 6.58 4.54
Apr 25 6.48 6.40 6.62 3.40
Apr 26 6.45 6.31 6.61 4.72
Apr 27 6.36 6.32 6.44 1.87
Apr 28 6.37 6.23 6.50 4.36
Apr 29 6.32 6.17 6.42 4.06
Apr 30 6.17 6.12 6.20 1.36
May 01 6.01 5.90 6.07 2.87
May 02 5.84 5.70 5.89 3.38
May 03 5.92 5.82 6.05 3.93
May 04 5.90 5.78 5.95 2.94
May 05 5.88 5.77 6.01 4.31
May 06 5.80 5.71 5.93 3.81
May 07 5.92 5.79 5.97 2.97
May 08 6.05 6.01 6.11 1.78
May 09 6.21 6.16 6.26 1.63
May 10 6.17 6.05 6.23 3.03
May 11 6.10 6.05 6.14 1.48
May 12 6.14 6.09 6.24 2.48
May 13 6.00 5.89 6.06 2.88
May 14 6.07 5.97 6.12 2.47
May 15 6.06 5.93 6.16 3.89
May 16 6.01 5.92 6.07 2.47
May 17 6.14 6.06 6.27 3.47
May 18 6.00 5.92 6.06 2.28
May 19 5.89 5.80 5.96 2.77
May 20 5.83 5.70 5.97 4.66
May 21 5.78 5.70 5.86 2.83

Atara Biotherapeutics Daily Price Targets


Atara Biotherapeutics Stock Forecast 04-22-2025.

Forecast target price for 04-22-2025: $6.42.
Positive dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.470%.
Pessimistic target level: 6.27
Optimistic target level: 6.49

Atara Biotherapeutics Stock Forecast 04-23-2025.

Forecast target price for 04-23-2025: $6.40.
Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.331%.
Pessimistic target level: 6.29
Optimistic target level: 6.51

Atara Biotherapeutics Stock Forecast 04-24-2025.

Forecast target price for 04-24-2025: $6.44.
Positive dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 4.345%.
Pessimistic target level: 6.30
Optimistic target level: 6.58

Atara Biotherapeutics Stock Forecast 04-25-2025.

Forecast target price for 04-25-2025: $6.48.
Positive dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 3.292%.
Pessimistic target level: 6.40
Optimistic target level: 6.62

Atara Biotherapeutics Stock Forecast 04-26-2025.

Forecast target price for 04-26-2025: $6.45.
Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 4.512%.
Pessimistic target level: 6.31
Optimistic target level: 6.61

Atara Biotherapeutics Stock Forecast 04-27-2025.

Forecast target price for 04-27-2025: $6.36.
Negative dynamics for Atara Biotherapeutics shares will prevail with possible volatility of 1.837%.
Pessimistic target level: 6.32
Optimistic target level: 6.44

ATRA (ATRA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
May. 6.13 5.85 6.71 12.81
Jun. 6.65 6.27 7.17 12.56
Jul. 6.63 6.15 7.12 13.53
Aug. 6.50 6.02 6.66 9.60
Sep. 6.14 5.97 6.46 7.64
Oct. 6.79 6.34 7.14 11.18
Nov. 6.78 6.17 7.21 14.34
Dec. 6.40 6.06 6.95 12.72

Atara Biotherapeutics forecast for this year


Atara Biotherapeutics Stock Prediction for May 2025

An downtrend is forecast for this month with an optimal target price of $6.12558. Pessimistic: $5.85. Optimistic: $6.71


Atara Biotherapeutics Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $6.64748. Pessimistic: $6.27. Optimistic: $7.17


Atara Biotherapeutics Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $6.63152. Pessimistic: $6.15. Optimistic: $7.12


Atara Biotherapeutics Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $6.49624. Pessimistic: $6.02. Optimistic: $6.66


Atara Biotherapeutics Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $6.13765. Pessimistic: $5.97. Optimistic: $6.46


Atara Biotherapeutics Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $6.79315. Pessimistic: $6.34. Optimistic: $7.14


Atara Biotherapeutics Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $6.78499. Pessimistic: $6.17. Optimistic: $7.21


Atara Biotherapeutics Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $6.40232. Pessimistic: $6.06. Optimistic: $6.95



Atara Biotherapeutics (ATRA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 6.79 6.36 7.29 12.73
Feb 6.20 5.61 6.48 13.33
Mar 5.90 5.49 6.16 10.92
Apr 5.93 5.37 6.46 16.86
May 6.48 5.91 7.00 15.55
Jun 6.49 6.21 6.74 7.96
Jul 6.60 6.34 7.16 11.40
Aug 6.79 6.23 7.28 14.44
Sep 6.65 6.33 6.94 8.85
Oct 6.49 6.22 7.07 12.00
Nov 6.87 6.29 7.12 11.69
Dec 7.17 6.85 7.77 11.86

Atara Biotherapeutics (ATRA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 6.72 6.21 6.91 10.15
Feb 6.63 6.15 6.98 11.85
Mar 6.29 5.73 6.84 16.22
Apr 6.02 5.68 6.30 9.96
May 6.21 6.02 6.45 6.70
Jun 5.97 5.69 6.43 11.48
Jul 6.45 5.96 6.95 14.25
Aug 5.85 5.41 6.09 11.29
Sep 5.54 5.25 5.91 11.13
Oct 4.91 4.75 5.07 6.39
Nov 4.75 4.53 4.96 8.62
Dec 4.71 4.47 5.07 11.84

Atara Biotherapeutics information and performance

Atara Biotherapeutics Address

611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO, CA, US

Market Capitalization: 36 149 500 $

Market capitalization of the Atara Biotherapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ATRA shares in the company outstanding by the market price of one share.

EBITDA: -73 280 000 $

EBITDA of Atara Biotherapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -11.41

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 6.7
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.291

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.347

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 5858900

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Atara Biotherapeutics Stock)

Should I Buy Atara Biotherapeutics Shares in 2025 year?

The maximum forecasted share price for next year is $7.17, which is $1.00 higher than the current stock price. By investing in Atara Biotherapeutics shares today for a one-year period, you could achieve a profit of 16.27%. With an investment horizon of up to two years, the target share price is $6.72. resulting in a profit of 8.87% ($0.55 per share).

Does Atara Biotherapeutics pay dividends?

No, it does not

Which economic sector do Atara Biotherapeutics's shares belong to?

Atara Biotherapeutics's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Atara Biotherapeutics's shares?

You can view all the stocks that are part of the same sector as Atara Biotherapeutics's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.